Document ID: chunk:federal_register_of_legislation:F2022L00258:reg:9:p3
Version: federal_register_of_legislation:F2022L00258
Segment Type: reg
Provision Reference: reg 9 (pt 3/6)
Character Range: 9895–13025

within 25 years of cessation;
(23)      inhaling, ingesting or having cutaneous contact with a chemical agent contaminated by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD):
(a)          for a cumulative period of at least 1,000 hours within a consecutive period of 10 years, before the clinical onset of hypertension; and
(b)          where the first exposure occurred at least 5 years before the clinical onset of hypertension; and
if that exposure has ceased before the clinical onset of hypertension, then that onset occurred within 25 years of cessation;
            Note: inhaling, ingesting or having cutaneous contact with a chemical agent contaminated by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) is defined in the Schedule 1 - Dictionary.
(24)      inhaling, ingesting or having cutaneous contact with a dioxin-like polychlorinated biphenyl:
(a)          for a cumulative period of at least 1,000 hours within a consecutive period of 10 years, before the clinical onset of hypertension; and
(b)          where the first exposure occurred at least 5 years before the clinical onset of hypertension; and
if that exposure has ceased before the clinical onset of hypertension, then that onset occurred within 25 years of cessation;
            Note: inhaling, ingesting or having cutaneous contact with a dioxin-like polychlorinated biphenyl is defined in the Schedule 1 – Dictionary.
(25)      inhaling ambient, chronically polluted air as specified for at least 1 year, within the 2 years before the clinical onset of hypertension;
Note: ambient, chronically polluted air as specified is defined in the Schedule 1 – Dictionary.
(26)      being overweight or obese for at least the 5 years before the clinical worsening of hypertension;
Note: being overweight or obese is defined in the Schedule 1 - Dictionary.
(27)      consuming an average of at least 250 grams of alcohol per week for a continuous period of at least the 6 months before the clinical worsening of hypertension;
            Note: Alcohol consumption is calculated utilising the Australian Standard of 10 grams of alcohol per standard alcoholic drink.
(28)      consuming an average of at least 9 grams (150 millimoles) of salt per day for at least the 1 year before the clinical worsening of hypertension;
            Note: Sodium-containing medications may contribute to daily salt intake. Sodium-containing medications include the effervescent or soluble version of standard medicines, such as acetaminophen, ascorbic acid, aspirin, calcium carbonate, ibuprofen, sodium bicarbonate and zinc sulphate.
(29)      having renal artery stenosis at the time of the clinical worsening of hypertension;
            Note: Causes of renal artery stenosis include renal artery atherosclerotic disease and fibromuscular dysplasia.
(30)      having a solid organ, stem cell or bone marrow transplant before the clinical worsening of hypertension;
(31)      having diabetes mellitus for at least the 5 years before the clinical worsening of hypertension;
(32)      having chronic kidney disease at the time of the clinical worsening of hypertension;
Note: chronic